Direkt zum Inhalt
Merck
  • Putative biomarker for phospholipid accumulation in cultured cells treated with phospholipidosis-inducing drugs: alteration of the phosphatidylinositol composition detected using high-performance liquid chromatography-tandem mass spectrometry.

Putative biomarker for phospholipid accumulation in cultured cells treated with phospholipidosis-inducing drugs: alteration of the phosphatidylinositol composition detected using high-performance liquid chromatography-tandem mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2014-08-03)
Ryohei Hamaguchi, Toshiko Tanimoto, Yukihiro Kuroda
ZUSAMMENFASSUNG

We developed a high-performance liquid chromatography-tandem mass spectrometric method for phospholipid biomarker discovery and applied it to a cell-based assay system for the screening of phospholipidosis-inducing drugs. We studied the compositions of phospholipid molecules exceeding 100 species in cultured cells and found a characteristic alteration in the composition by treatment with cationic amphiphilic drugs possessing phospholipidosis-inducing potency. The compositions of phosphatidylinositol in RAW264 cells were significantly affected by the drug treatment. Similar alterations were also found in THP-1 cells. These phenomena were not observed when cells were treated with warfarin, which does not have phospholipidosis-inducing potency. Structural analysis of the altered phosphatidylinositols by a product ion scan revealed the presence of certain fatty acyl chains. Based on our findings, we proposed a prediction parameter (PP) for phospholipid accumulation calculated from the relative compositions of phosphatidylinositol species. As the dosage of imipramine (a cationic amphiphilic drug) increased, both the PP and cellular phospholipid content increased. Our results suggest that PP has potency as a biomarker for phospholipid accumulation in cells treated with drugs.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Methanol, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Methanol, HPLC Plus, ≥99.9%
Sigma-Aldrich
Ammoniak -Lösung, 7 N in methanol
Sigma-Aldrich
Ammoniumformat, reagent grade, 97%
Sigma-Aldrich
Methanol, suitable for HPLC, gradient grade, suitable as ACS-grade LC reagent, ≥99.9%
Sigma-Aldrich
L-Glutamin, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
Methanol, Laboratory Reagent, ≥99.6%
Supelco
Ammoniumformat, eluent additive for LC-MS, LiChropur, ≥99.0%
Sigma-Aldrich
L-Glutamin
Sigma-Aldrich
Methanol, anhydrous, 99.8%
Sigma-Aldrich
Ammoniumformat, ≥99.995% trace metals basis
Sigma-Aldrich
Methanol, BioReagent, ≥99.93%
Sigma-Aldrich
Methanol, Absolute - Acetone free
Sigma-Aldrich
Methanol, ACS spectrophotometric grade, ≥99.9%
SAFC
L-Glutamin
Sigma-Aldrich
Ammoniumformiat -Lösung, BioUltra, 10 M in H2O
Sigma-Aldrich
Ammoniak -Lösung, 0.4 M in dioxane
Sigma-Aldrich
Ammoniak -Lösung, 2.0 M in ethanol
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Ammoniak, anhydrous, ≥99.98%
USP
Methylalkohol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Ammoniak -Lösung, 4 M in methanol
Sigma-Aldrich
Chlorpromazin -hydrochlorid, ≥98% (TLC)
Sigma-Aldrich
Ammoniak -Lösung, 0.4 M in THF
Supelco
Methanol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutamin, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
Methanol, ACS reagent, ≥99.8%
Sigma-Aldrich
Ammoniak -Lösung, 2.0 M in isopropanol
Sigma-Aldrich
Imipramin -hydrochlorid, ≥99% (TLC)